Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants expanded approval for Novartis' Promacta in first-line severe aplastic anaemia

firstwordpharmaNovember 19, 2018

Tag: Top Story , Promacta , Eltrombopag

PharmaSources Customer Service